Identification of Novel Potential miRNA and mRNA Biomarkers in High Myopia Using Systems Biology Approaches Identification biomarker in high myopia
Journal of Ophthalmic and Optometric Sciences,
Vol. 6 No. 2 (2022),
8 Aban 2023
,
Page 12-22
https://doi.org/10.22037/joos.v6i2.41600
Abstract
Background: Myopia, also known as shortsightedness, is a common eye disorder characterized by a refractive error of the eye. It is estimated that by 2050, over 1 billion people will be affected by myopia. Recent studies have shown that miRNAs play a significant role in the genetic factors contributing to myopia.
Materials and Methods: The raw dataset (GSE142359), consisting of miRNAs, was obtained from the GEO database. The dataset includes 10 samples, 5 from patients with high myopia and 5 from controls. Differentially expressed genes were identified using the EdgeR package in R software. The most significant miRNAs were then entered as input into the miRWalk web tool and target genes were identified. Subsequently, the PPI network was extracted using STRING and 10 clusters were identified.
Results: A total of 136 miRNAs were identified as significant differentially expressed miRNAs (DEmiRNAs). Then, we constructed miRNA-mRNA bipartite network with 564 interactions including 490 genes and 50 miRNAs. Afterwards, 5 miRNAs including: hsa-miR-195-5p, hsa-miR-24-3p, hsa-miR-16-5p, hsa-miR-181b-5p, and hsa-miR-130a-3p and 8 proteins including ESR1, BCL2, VEGFA, FGF2, MAPK14, H2AX, APP, and MAP3K10 were identified. Finally, two new miRNAs including hsa-miR-195-5p and hsa-miR-24-3p, and three novel proteins including: ESR1, BCL2, and MAPK14 were proposed as potential biomarker in high myopia.
Conclusion: This study revealed new miRNAs previously unknown in highly myopic eyes through bioinformatics analysis. The identified candidate miRNAs and their related drug targets and genes can serve as potential biomarkers, improving the understanding of new therapeutic targets for highly myopic eyes.
- Myopia
- NGS Data
- MicroRNA
- Differential Gene Expression
- Drug- Gene Network
- 2022-04-03 (3)
- 2023-11-08 (2)
- 2022-04-01 (1)
How to Cite
References
Wen K, Shao X, Li Y, Li Y, Li Y, Wang Q, et al. The plasminogen protein is associated with high myopia as revealed by the iTRAQ-based proteomic analysis of the aqueous humor. Scientific reports. 2021;11(1):1-13.
Liu Y, Zhang J-J, Piao S-Y, Shen R-J, Ma Y, Xue Z-Q, et al. Whole-Exome Sequencing in a Cohort of High Myopia Patients in Northwest China. Frontiers in cell and developmental biology. 2021;9:1604.
González-Iglesias E, López-Vázquez A, Noval S, Nieves-Moreno M, Granados-Fernández M, Arruti N, et al. Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study. International Journal of Molecular Sciences. 2022;23(8):4233.
Li Q, Zheng Q, He J, Li L, Xie X, Liang H. Hsa-miR-142-3p reduces collagen I in human scleral fibroblasts by targeting TGF-β1 in high myopia. Experimental Eye Research. 2022;219:109023.
Li J, Zhang Q. Insight into the molecular genetics of myopia. Molecular vision. 2017;23:1048.
Zhu Y, Li W, Zhu D, Zhou J. microRNA profiling in the aqueous humor of highly myopic eyes using next generation sequencing. Experimental eye research. 2020;195:108034.
Chen K-C, Hsi E, Hu C-Y, Chou W-W, Liang C-L, Juo S-HH. MicroRNA-328 may influence myopia development by mediating the PAX6 gene. Investigative ophthalmology & visual science. 2012;53(6):2732-9.
Jiang B, Huo Y, Gu Y, Wang J. The role of microRNAs in myopia. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:7-13.
Metlapally R, Park HN, Chakraborty R, Wang KK, Tan CC, Light JG, et al. Genome-wide scleral micro-and messenger-RNA regulation during myopia development in the mouse. Investigative ophthalmology & visual science. 2016;57(14):6089-97.
Xie M, Li Y, Wu J, Wu J. Genetic variants in MiR-29a associated with high myopia. Ophthalmic genetics. 2016;37(4):456-8.
Zhu Y, Zhang Y, Jiang R, Zhao K, Zhou J. MicroRNA-29a may influence myopia development by regulating collagen I. Current Eye Research. 2022;47(3):468-76.
Mei F, Wang J, Chen Z, Yuan Z. Potentially important MicroRNAs in form-deprivation myopia revealed by bioinformatics analysis of MicroRNA profiling. Ophthalmic Research. 2017;57(3):186-93.
Abedi Z, MotieGhader H, Maghsoudloo M, Goharrizi MASB, Shojaei A. Novel potential drugs for therapy of age-related macular degeneration using Protein-Protein Interaction Network (PPIN) analysis. Journal of Ophthalmic and Optometric Sciences. 2019;3(4).
Maghsoudloo M, Noroozizadeh MH. A gene selection approach for Diabetic retinopathy microarray data classification using Ant Colony Optimization. Journal of Ophthalmic and Optometric Sciences.3(4):1-10.
Dweep H, Sticht C, Pandey P, Gretz N. miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. Journal of biomedical informatics. 2011;44(5):839-47.
Maghsoudloo M, Noroozizadeh MH. Collagen Cross-Linking Therapy on Important Functional Genes Involved in Keratoconus Patients Using Protein-Protein Interactions (PPI) Network and Differential Expression Analysis. Journal of Ophthalmic and Optometric Sciences Volume. 2019;3(3).
Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic acids research. 2009;37(suppl_2):W305-W11.
Afhami N, Maghsoudloo M, Shojaei A, Moghadam FA. Suggested Drugs for Human Strabismic Extraocular Muscle. Journal of Ophthalmic and Optometric Sciences. 2020;4(3):17-31.
Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, et al. Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic acids research. 2021;49(D1):D1144-D51.
Mahmanzar M, Maghsoudloo M, Moghadam FA, Shojaei A. Construction of experimentally validated lncRNA-miRNA‐mRNA regulatory network in Keratoconus. Journal of Ophthalmic and Optometric Sciences. 2020;4(4).
Vishweswaraiah S, Swierkowska J, Ratnamala U, Mishra NK, Guda C, Chettiar SS, et al. Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia. Scientific reports. 2019;9(1):4145.
An J, Hsi E, Zhou X, Tao Y, Juo S-HH, Liang C-L. The FGF2 gene in a myopia animal model and human subjects. Molecular Vision. 2012;18:471.
Ritchey ER, Zelinka CP, Tang J, Liu J, Fischer AJ. The combination of IGF1 and FGF2 and the induction of excessive ocular growth and extreme myopia. Experimental eye research. 2012;99:1-16.
Zhu X, Dellostritto S, Nour A, Benavente-Perez A. Vascular Endothelial Growth Factor-A (VEGF-A) and High Myopia in Marmosets. Investigative Ophthalmology & Visual Science. 2021;62(8):2875.
de Voogd S, Wolfs RC, Jansonius NM, Uitterlinden AG, Pols HA, Hofman A, et al. Estrogen receptors alpha and beta and the risk of open-angle glaucoma: the Rotterdam Study. Archives of ophthalmology. 2008;126(1):110-4.
Ulhaq ZS. The association between genetic polymorphisms in estrogen receptor genes and the risk of ocular disease: a meta-analysis. Turkish Journal of Ophthalmology. 2020;50(4):216.
Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t (14; 18) translocation. Cell. 1986;47(1):19-28.
Zhang Y, Atchaneeyasakul LO, McFarland T, Appukuttan B, Stout J. Down Regulation of Anti–Apoptotic Genes Bcl–2 and Bcl–xL Expression in a Rat Model of Central Retinal Artery Occlusion. Investigative Ophthalmology & Visual Science. 2005;46(13):5321.
Dong L-F, Yao J, Wang X-Q, Shan K, Yang H, Yan B, et al. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder. Biochemical and Biophysical Research Communications. 2015;465(4):678-84.
- Abstract Viewed: 112 times
- pdf Downloaded: 41 times
